Qube Research & Technologies (QRT)
NXTC icon

Qube Research & Technologies (QRT)’s NextCure NXTC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$76 – 3869
2024
Q2 		$76 Hold
4
– – ﹤0.01% 3456
2024
Q1 		$107 Hold
4
– – ﹤0.01% 4175
2023
Q4 		$55 Hold
4
– – ﹤0.01% 4063
2023
Q3 		$62 Buy
+4
New +$76 ﹤0.01% 3799

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NXTC Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of NextCure (NXTC) in Q3 2024, closing a stake of 4 shares — an estimated $76 sold.

Qube Research & Technologies (QRT) first reported a position in NXTC in Q3 2023 and held it in 4 quarters. The position peaked at $107 in Q1 2024. 43 funds tracked by Wall St. Rank hold NXTC as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining NextCure position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 4 NextCure shares in Q3 2024, an estimated $76.
  • Qube Research & Technologies (QRT) first reported a position in NextCure in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s NextCure position peaked at $107 in Q1 2024.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.